Carlyle: Travelers CEO steps off board to fight illness - 10/28/2015

In the Margins

Carlyle: Travelers CEO steps off board to fight illness

October 28, 2015

By Bloomberg

Carlyle Group LP said Travelers Cos. CEO Jay Fishman stepped down from its board while fighting amyotrophic lateral sclerosis, or ALS. Fishman, 62, said in August he would be replaced as Travelers CEO on Dec. 1 by Alan Schnitzer and stay on as executive chairman. Anthony Welters, executive chairman of investment company Black Ivy Group and a senior adviser to the office of the CEO at UnitedHealth Group Inc., has joined the Carlyle board as independent director. Read the original story from Bloomberg.

Share Feedback Post on LinkedIn Share Article

Most Read

A Seat at the Table
Guinness Atkinson Funds board repopulates, adds flexibility

Guinness Atkinson Funds has added two new independent directors to bump the size of the board back up to six members following the year-end retirement of ...

Viewpoints
SEC in 2025 (and beyond): How will Atkins shape the regulator?

Securities and Exchange Commission Chairman Gary Gensler’s fast and furious rulemaking era will soon be ending, and it is a good time to take stock of ...

10 Things
10 Things...to know about BDCs

Congress created business development companies in 1980 to support job growth and help emerging companies raise funds. As of 2023, there were 139 BDCs with $312 ...

Top of the Agenda - Succession
Vanguard nominates two, as two hit retirement

The Vanguard board expects to add two new independent directors in early 2025 to fill seats that will be vacated when two long-serving independents retire. The ...